Occudo Quantitative Strategies’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,289
Closed -$270K 970
2024
Q4
$270K Buy
+5,289
New +$260K 0.05% 487
2023
Q3
Sell
-18,417
Closed -$1.07M 1368
2023
Q2
$1.07M Sell
18,417
-2,797
-13% -$176K 0.11% 308
2023
Q1
$1.31M Buy
21,214
+14,837
+233% +$890K 0.12% 253
2022
Q4
$405K Sell
6,377
-12,082
-65% -$876K 0.05% 573
2022
Q3
$1.34M Buy
+18,459
New +$1.37M 0.1% 289
2021
Q3
Sell
-5,997
Closed -$559K 1178
2021
Q2
$559K Sell
5,997
-5,184
-46% -$503K 0.09% 392
2021
Q1
$1.2M Sell
11,181
-11,854
-51% -$1.23M 0.26% 93
2020
Q4
$2.01M Buy
+23,035
New +$1.63M 0.63% 4

Other funds holding NARI

Occudo Quantitative Strategies's NARI Position: Q1 2025 in Review

Occudo Quantitative Strategies sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 5,289 shares — an estimated $270K sold.

Occudo Quantitative Strategies first reported a position in NARI in Q4 2020 and held it in 8 quarters. The position peaked at $2.01M in Q4 2020. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Occudo Quantitative Strategies reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,289 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $270K.
  • Occudo Quantitative Strategies first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Occudo Quantitative Strategies's Inari Medical, Inc. Common Stock position peaked at $2.01M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2025, filed 15 May 2025.